Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 147

Similar articles for PubMed (Select 23047841)

1.

Arterial spin-labeling MR imaging of renal masses: correlation with histopathologic findings.

Lanzman RS, Robson PM, Sun MR, Patel AD, Mentore K, Wagner AA, Genega EM, Rofsky NM, Alsop DC, Pedrosa I.

Radiology. 2012 Dec;265(3):799-808. doi: 10.1148/radiol.12112260. Epub 2012 Oct 9.

2.

Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.

Sun MR, Ngo L, Genega EM, Atkins MB, Finn ME, Rofsky NM, Pedrosa I.

Radiology. 2009 Mar;250(3):793-802. doi: 10.1148/radiol.2503080995.

PMID:
19244046
3.

Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.

Young JR, Margolis D, Sauk S, Pantuck AJ, Sayre J, Raman SS.

Radiology. 2013 May;267(2):444-53. doi: 10.1148/radiol.13112617. Epub 2013 Feb 4.

PMID:
23382290
4.

Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours.

Cornelis F, Tricaud E, Lasserre AS, Petitpierre F, Bernhard JC, Le Bras Y, Yacoub M, Bouzgarrou M, Ravaud A, Grenier N.

Eur Radiol. 2014 May;24(5):1068-80. doi: 10.1007/s00330-014-3107-z. Epub 2014 Feb 21.

PMID:
24557052
5.

Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.

Wang H, Cheng L, Zhang X, Wang D, Guo A, Gao Y, Ye H.

Radiology. 2010 Oct;257(1):135-43. doi: 10.1148/radiol.10092396. Epub 2010 Aug 16.

PMID:
20713607
6.

Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model?

Schor-Bardach R, Alsop DC, Pedrosa I, Solazzo SA, Wang X, Marquis RP, Atkins MB, Regan M, Signoretti S, Lenkinski RE, Goldberg SN.

Radiology. 2009 Jun;251(3):731-42. doi: 10.1148/radiol.2521081059. Erratum in: Radiology. 2009 Dec;253(3):900.

7.

MR imaging of renal cortical tumours: qualitative and quantitative chemical shift imaging parameters.

Karlo CA, Donati OF, Burger IA, Zheng J, Moskowitz CS, Hricak H, Akin O.

Eur Radiol. 2013 Jun;23(6):1738-44. doi: 10.1007/s00330-012-2758-x. Epub 2013 Jan 10.

PMID:
23300041
9.

Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula.

Kopp RP, Aganovic L, Palazzi KL, Cassidy FH, Sakamoto K, Derweesh IH.

Can J Urol. 2013 Jun;20(3):6790-7.

PMID:
23783049
10.

Arterial spin labeling MR imaging for characterisation of renal masses in patients with impaired renal function: initial experience.

Pedrosa I, Rafatzand K, Robson P, Wagner AA, Atkins MB, Rofsky NM, Alsop DC.

Eur Radiol. 2012 Feb;22(2):484-92. doi: 10.1007/s00330-011-2250-z. Epub 2011 Aug 30.

PMID:
21877173
11.

Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses.

Lee-Felker SA, Felker ER, Tan N, Margolis DJ, Young JR, Sayre J, Raman SS.

AJR Am J Roentgenol. 2014 Nov;203(5):W516-24. doi: 10.2214/AJR.14.12460.

PMID:
25341166
12.

Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging.

Taouli B, Thakur RK, Mannelli L, Babb JS, Kim S, Hecht EM, Lee VS, Israel GM.

Radiology. 2009 May;251(2):398-407. doi: 10.1148/radiol.2512080880. Epub 2009 Mar 10.

PMID:
19276322
13.

Exophytic renal masses: angular interface with renal parenchyma for distinguishing benign from malignant lesions at MR imaging.

Verma SK, Mitchell DG, Yang R, Roth CG, O'Kane P, Verma M, Parker L.

Radiology. 2010 May;255(2):501-7. doi: 10.1148/radiol.09091109. Epub 2010 Feb 16.

PMID:
20160001
14.

Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI.

Choi YA, Kim CK, Park SY, Cho SW, Park BK.

AJR Am J Roentgenol. 2014 Jul;203(1):W78-84. doi: 10.2214/AJR.13.11551.

PMID:
24951231
15.

Exposed proliferation antigen 210 (XPA-210) in renal cell carcinoma (RCC) and oncocytoma: clinical utility and biological implications.

Kruck S, Hennenlotter J, Vogel U, Schilling D, Gakis G, Hevler J, Kuehs U, Stenzl A, Schwentner C.

BJU Int. 2012 Feb;109(4):634-8. doi: 10.1111/j.1464-410X.2011.10392.x. Epub 2011 Jun 28.

PMID:
21711439
16.

Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques?

Hindman N, Ngo L, Genega EM, Melamed J, Wei J, Braza JM, Rofsky NM, Pedrosa I.

Radiology. 2012 Nov;265(2):468-77. doi: 10.1148/radiol.12112087. Epub 2012 Sep 25.

17.

Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma.

Pierorazio PM, Hyams ES, Tsai S, Feng Z, Trock BJ, Mullins JK, Johnson PT, Fishman EK, Allaf ME.

Urology. 2013 Jun;81(6):1265-71. doi: 10.1016/j.urology.2012.12.049. Epub 2013 Apr 17.

PMID:
23601445
18.

Antimitochondrial antibody (113-1) in the differential diagnosis of granular renal cell tumors.

Tickoo SK, Amin MB, Linden MD, Lee MW, Zarbo RJ.

Am J Surg Pathol. 1997 Aug;21(8):922-30.

PMID:
9255255
19.

Histogram analysis of whole-lesion enhancement in differentiating clear cell from papillary subtype of renal cell cancer.

Chandarana H, Rosenkrantz AB, Mussi TC, Kim S, Ahmad AA, Raj SD, McMenamy J, Melamed J, Babb JS, Kiefer B, Kiraly AP.

Radiology. 2012 Dec;265(3):790-8. doi: 10.1148/radiol.12111281.

PMID:
23175544
20.

Comparison of accuracy of 14-, 18- and 20-G needles in ex-vivo renal mass biopsy: a prospective, blinded study.

Breda A, Treat EG, Haft-Candell L, Leppert JT, Harper JD, Said J, Raman S, Smith RB, Belldegrun AS, Schulam PG.

BJU Int. 2010 Apr;105(7):940-5. doi: 10.1111/j.1464-410X.2009.08989.x. Epub 2009 Nov 2.

PMID:
19888984
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk